Kalbe Farma Tbk vs Sinergi Multi Lestarindo Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp144 (market cap 298B, 13.54M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 110.7× Sinergi Multi Lestarindo Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 13.54M). Which is the better fit depends on your goals.
| KLBF | SMLE | |
|---|---|---|
Market Cap | 33T | 298B |
Volume | 98.44M | 13.54M |
Lot | 984.38K | 135.37K |
Turnover | 70.64B | 1.83B |
Average Price | 717.58 | 135.02 |
Value | 70.64B | 1.83B |
Indicative Equilibrium Price | 720 | 144 |
Indicative Equilibrium Volume | 43.62K | 1.56K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.
Read more on SMLE →